Elsevier Science

36, No.4 INDUCTION OF OVULATION WITH SPIRONOLACTONE 469 were performed before and during every treat­ ment cycle. 0000001918 00000 n The spironolactone was administered daily from the 5th until the 21st day of the cycle throughout six cycles, in a dosage of 100 to 150 mg/day. In addition, improvement of hirsutism was observed in 9 (70%) and restoration of regular cycles in 11 (85%) of the patients. 0000001827 00000 n Name must be less than 100 characters 1982 Jul;34(7):939-44.Amin M, Simerman A, Cho M, Singh P, Briton-Jones C, Hill D, Grogan T, Elashoff D, Clarke NJ, Chazenbalk GD, Dumesic DA.J Clin Endocrinol Metab. <<8E8F6DC8F91269459D1E515E887B87E4>]>> 1987;240(2):67-73. doi: 10.1007/BF02134038.Masahashi T, Wu MC, Ohsawa M, Asai M, Ichikawa Y, Hanai K, Kikkawa H, Mizutani S, Narita O, Tomoda Y.Nihon Sanka Fujinka Gakkai Zasshi. Spironolactone is a potassium-sparing diuretic (water pill) that prevents your body from absorbing too much salt and keeps your potassium levels from getting too low.. Spironolactone is used to treat heart failure, high blood pressure (hypertension), or hypokalemia (low potassium levels in the blood).. Spironolactone also treats fluid retention (edema) in … 0000010021 00000 n 0000005337 00000 n 0 0000011070 00000 n The dose of spironolactone for acne in females is 50 - 150mg a day … Clipboard, Search History, and several other advanced features are temporarily unavailable. 1987;240(2):67-73. doi: 10.1007/BF02134038.Arch Gynecol. 0000000016 00000 n \�%|@Z �e�"�@��l xسX\�22hdp *��l#2`H`P��F���"H���X�of ����f��NULM � 1986 Jan;38(1):95-101.Am J Obstet Gynecol. 0000000676 00000 n x�b```��,��s@(� Siegberg R, Ylöstalo P, Laatikainen T, Pelkonen R, Stenman UH.Arch Gynecol. Vol. doi: 10.1016/s0015-0282(16)45795-x. This information is generalized and not intended as specific medical advice. 0000008857 00000 n 1983 Jan 15;145(2):152-7. doi: 10.1016/0002-9378(83)90482-9.Fertil Steril. 0000001643 00000 n Please enable it to take advantage of the complete set of features! endstream endobj 30 0 obj <>/Type/Catalog/PageLabels<>1< 29 0 obj <> endobj 1. Unable to load your delegates due to an error The side effects observed were mild and did not lead to interruption of the treatment. 0000006465 00000 n 1984 Jun;41(6):888-93. doi: 10.1016/s0015-0282(16)47903-3.Nihon Sanka Fujinka Gakkai Zasshi. Fertil Steril. 1993 Dec;16(11):925-32. doi: 10.1007/BF03348960.Siegberg R, Ylöstalo P, Laatikainen T, Pelkonen R, Stenman UH.Arch Gynecol. xref 0000007586 00000 n Spironolactone is currently being used in dermatology as an antiandrogen or anti-male hormone therapy for the treatment of acne, diffuse hair loss in females, and hirsutism. Csaba IF, Nagy P. PMID: 7117563 [PubMed - indexed for MEDLINE] 0000002010 00000 n %%EOF Thirteen anovulatory oligomenorrheic, hyperandrogenic, and normoprolactinemic women were treated with spironolactone (aldactone) throughout six consecutive menstrual cycles in a dosage of 100 to 150 mg/day. 0000001737 00000 n Acne improves within 2 to 4 months and skin oiliness decreases. Elsevier Science 0000008768 00000 n This site needs JavaScript to work properly. During this treatment a significant decrease in serum luteinizing hormone (LH), testosterone, prolactin, and 17-ketosteroid values were observed that were accompanied by ovulation in 11 women (85%), according to basal body temperature (BBT) and progesterone values. Eplerenone; Spironolactone/NSAIDs Interactions. 0000001308 00000 n